1-3 of 3
Dhavalkumar D. Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

Clinical Trials & Observations
V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm, Anna Šedivá, P. Martin van Hagen, Steven Holland, Sergio D. Rosenzweig, Andreas D. Christ, Birgitte Sloth, Maciej Cabanski, Aniket D. Joshi, Stefan de Buck, Julie Doucet, Danilo Guerini, Christoph Kalis, Ilona Pylvaenaeinen, Nicolas Soldermann, Anuj Kashyap, Gulbu Uzel, Michael J. Lenardo, Dhavalkumar D. Patel, Carrie L. Lucas, Christoph Burkhart
Journal: Blood
Blood (2017) 130 (21): 2307–2316.
https://doi.org/10.1182/blood-2017-08-801191
Published: 2017
Includes: Supplemental data
Journal Articles

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

Sang-Hoon Sin, Debasmita Roy, Ling Wang, Michelle R. Staudt, Farnaz D. Fakhari, Dhavalkumar D. Patel, David Henry, William J. Harrington, Jr, Blossom A. Damania, Dirk P. Dittmer
Journal: Blood
Blood (2006) 109 (5): 2165–2173.
https://doi.org/10.1182/blood-2006-06-028092
Published: 2006
Includes: Supplemental data
Journal Articles

Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival

Clinical Trials & Observations
Laurie A. Myers, Dhavalkumar D. Patel, Jennifer M. Puck, Rebecca H. Buckley
Journal: Blood
Blood (2002) 99 (3): 872–878.
https://doi.org/10.1182/blood.V99.3.872
Published: 2002